2020
DOI: 10.14802/jmd.19077
|View full text |Cite
|
Sign up to set email alerts
|

A Rare Case of Late Adult-Onset Niemann-Pick Disease Type C

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
(17 reference statements)
0
2
0
Order By: Relevance
“…2 Although usually these symptoms begin before the fourth decade, 2 the first symptoms in our patients presented in the fifth and sixth decades, respectively, which is extremely rare. 3,14 To the best of our knowledge, patient 2 is only the third case to be reported with age of onset at or after 55 years old 14,15 and only the second case to be reported with an age of diagnosis after 65 years old. 16 Both of our patients had a delay in diagnosis of 13 years, which is similar to prior reports in patients with NPC diagnosed >50 years of age, with a median delay in diagnosis of 13.25 years.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…2 Although usually these symptoms begin before the fourth decade, 2 the first symptoms in our patients presented in the fifth and sixth decades, respectively, which is extremely rare. 3,14 To the best of our knowledge, patient 2 is only the third case to be reported with age of onset at or after 55 years old 14,15 and only the second case to be reported with an age of diagnosis after 65 years old. 16 Both of our patients had a delay in diagnosis of 13 years, which is similar to prior reports in patients with NPC diagnosed >50 years of age, with a median delay in diagnosis of 13.25 years.…”
Section: Discussionmentioning
confidence: 90%
“…16 Both of our patients had a delay in diagnosis of 13 years, which is similar to prior reports in patients with NPC diagnosed >50 years of age, with a median delay in diagnosis of 13.25 years. 3,[14][15][16][17][18][19] For patients with a clinical profile suggesting NPC, oxysterols are the most widely used biomarkers with good accuracy. Plasma cholestane-3β,5α,6β-triol, 7-ketocholesterol are elevated, with cholestane-3β,5α,6β-triol being the preferred oxysterol biomarker because of its high specificity and sensitivity for NPC.…”
Section: Discussionmentioning
confidence: 99%